- Report
- March 2024
- 125 Pages
Asia Pacific
From €1433EUR$1,500USD£1,198GBP
- Report
- March 2021
- 183 Pages
Global
From €3438EUR$3,600USD£2,875GBP
- Report
- May 2022
- 109 Pages
South Africa
From €2722EUR$2,850USD£2,276GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €478EUR$500USD£399GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£759GBP
Expectorants are a type of cough and cold drug used to treat chest congestion. They work by thinning and loosening mucus in the airways, making it easier to cough up and expel. Expectorants are often used in combination with other medications, such as decongestants, to provide relief from symptoms of the common cold. They are available in both over-the-counter and prescription forms.
Expectorants are generally considered safe for use in adults and children over the age of two. However, they should be used with caution in people with certain medical conditions, such as asthma, chronic bronchitis, and heart disease.
Some of the companies in the expectorant market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more